Deutsche Bank Adjusts Clorox (CLX) Valuation Following GOJO Purchase

The Clorox Company (NYSE:CLX) is included among the Best Low Risk Stocks for a Retirement Stock Portfolio.

Deutsche Bank Adjusts Clorox (CLX) Valuation Following GOJO Purchase

Deutsche Bank lifted its price target on The Clorox Company (NYSE:CLX) on January 23  to $114 from $110. The firm maintained a Hold rating on the stock.

A day earlier, Clorox announced plans to acquire privately owned GOJO Industries for $2.25 billion in cash, a move aimed at strengthening its footprint in the health and hygiene space. GOJO, best known for its Purell hand sanitizer, saw demand surge during the pandemic before returning to more typical levels. Back in September, sources told Reuters the company was weighing several options, including a full sale or the sale of a minority stake.

The transaction values GOJO at $1.92 billion, with roughly $330 million tied to anticipated tax benefits, bringing the total deal value to $2.25 billion. Clorox expects to finance most of the purchase with debt and plans to close the deal before the end of its fiscal 2026. Management said the acquisition should deliver at least $50 million in annual cost synergies once fully integrated. GOJO will continue to be headquartered in Ohio and will be absorbed into Clorox’s existing operations.

Clorox is a global producer of consumer and professional products, operating across four main segments: Health and Wellness, Household, Lifestyle, and International.

While we acknowledge the potential of CLX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CLX and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 15 Best S&P 500 Dividend Stocks to Buy in 2026 and 12 Most Profitable Dividend Stocks to Buy in 2026

Disclosure: None.